Table 1.
Patient clinical and pathologic characteristics in the contemporary cohort
| Variables | Total (%) |
|---|---|
| No patients (%) | 1,987 (100) |
| Age, year, median (IQR) | 65 (62–69) |
| Pre-operative PSA (ng/mL), median (IQR) | 6.4 (4.7–9.6) |
| Pathologic Gleason score, n (%) | |
| ≤7 | 1,500 (75.5) |
| 8 | 220 (11.1) |
| ≥9 | 264 (13.3) |
| Unknown | 3 (0.2) |
| Pathologic stage, n (%) | |
| T2 | 772 (38.9) |
| T3a | 780 (39.3) |
| T3b | 390 (19.6) |
| T4 | 14 (0.7) |
| Unknown | 31 (1.6) |
| Positive surgical margins, n (%) | 1,100 (55.4) |
| Lymph node invasion, n (%) | 51 (2.6) |
Abbreviations: IQR, interquartile range; PSA, prostate-specific antigen.